Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol for Prevention of Cardiotoxicity in HER2+ Breast Cancer
NCT02177175Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2014
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carvedilol in Cardiotoxicity, sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 2014; status: completed.
02
Drugs
carvedilol
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT02177175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177175.